Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Glenn R. Masson
Oncogenic Mutations Mimic and Enhance Dynamic Events in the Natural Activation of Phosphoinositide 3-Kinase P110 (PIK3CA)
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Analysis of Phosphoinositide 3-Kinase Inhibitors by Bottom-Up Electron-Transfer Dissociation Hydrogen/Deuterium Exchange Mass Spectrometry
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Related publications
Constitutive Phosphoinositide 3-Kinase Activation in Acute Myeloid Leukemia Is Not Due to P110δ Mutations
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Multiple Phosphoinositide 3-Kinase-Dependent Steps in Activation of Protein Kinase B
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Essential, Nonredundant Role for the Phosphoinositide 3-Kinase P110 in Signaling by the B-Cell Receptor Complex
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Targeting the Phosphoinositide 3-Kinase P110- Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Gβγ Stimulates Phosphoinositide 3-Kinase-Γ by Direct Interaction With Two Domains of the Catalytic P110 Subunit
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Phosphatidylinositol 3-Kinase Mutations Identified in Human Cancer Are Oncogenic
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Phosphoinositide 3-Kinase Mutations in Breast Cancer: A "Good" Activating Mutation?
Clinical Cancer Research
Cancer Research
Oncology
Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases
Frontiers in Immunology
Allergy
Immunology
Phosphoinositide 3-Kinase Inhibitors in Lymphoma
Current Opinion in Oncology
Cancer Research
Oncology